AI predicts liver cancer risk with "high accuracy"
A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
Newsletters and Deep Dive digital magazine
A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data.
Recent developments in the biopharma AI world include a big financing for Verily, and updates from Zealand, Latent Labs, Insilico, and BMS/insitro.
A hacking group claims to have broken into AstraZeneca's IT systems and stolen confidential data, which they are now offering for sale.
Editor's Picks
Newsletters and Deep Dive
digital magazine